Dr. Steven M Albelda MD
Pulmonologist | Pulmonary Disease
3400 Spruce Street 3 Ravdin Building, S Philadelphia PA, 19104About
Dr. Steven Albelda practices Pulmonology in Philadelphia, PA. A pulmonologist is a physician who possesses specialized knowledge and skill in the diagnosis and treatment of pulmonary conditions and diseases. Dr. Albelda manages patients who need life support and mechanical ventilation, and is specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections.
Education and Training
Perelman School of Medicine at the University of Pennsylvania 1979
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Critical Care Medicine
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine
- Streptavidin facilitates internalization and pulmonary targeting of an
- Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer.
- The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
- Immunotargeting of glucose oxidase: intracellular production of H(2)O(2) and endothelial oxidative stress.
- Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
- Advances in the treatment of malignant pleural mesothelioma.
- Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer.
- Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
- A rapid and sensitive method for the quantification of ganciclovir in plasma using liquid chromatography/selected reaction monitoring/mass spectrometry.
- Contributions of the extracellular and cytoplasmic domains of
- Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.
- Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
- Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.
- Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
Dr. Steven M Albelda MD's Practice location
Dr. Steven M Albelda MD's reviews
Write ReviewRecommended Articles
- Does Cystic Fibrosis Run in the Family?
Cystic fibrosis is a disease affecting many people throughout the United States and the world. Yet, there is so much information out there that it is sometimes difficult to ascertain the most important facts. With this disease, you may have many lingering questions. How does someone get cystic...
- What Is Orthopnea?
OrthopneaOrthopnea is a condition that causes breathing difficulties when an individual is lying down. It usually happens at night when the person is going to sleep. People with orthopnea usually experience tightness in the chest and being oxygen-deficit. The shortness of breath is due to lying down...
- What Is Asthma: Get the Facts
Asthma is a lung condition where the lung bronchioles constrict and get filled with mucus, narrowing the passage for air to pass through. It is a non-curable condition. However, the symptoms can be suppressed with proper medication, exercise (as prescribed by the doctor, or else, doing inappropriate...
- Study Concludes At-home Antibiotic Therapy for Cystic Fibrosis No Riskier than at Hospital
Many patients would generally perform to have their treatments done at home than in a hospital; it's a familiar place, the patient can be more comfortable, travel isn’t necessary. It was assumed, however, that intravenous antibiotic treatment for cystic fibrosis patients would not be as safe at...
- New, Promising Cystic Fibrosis Drug Needs Funding
Canada has the highest rate of cystic fibrosis in the entire world, with approximately 1 in 134 citizens suffering from the disease. However, a recent drug that has been found to be "life changing" for some cystic fibrosis patients is not being funded.Official responseHealth Minister Adrian Dix...
- What Is the Treatment of Choice for Pneumonia?
Pneumonia is a lung infection that affects the air sacs. The sacs are either filled with fluid or pus causing a cough with phlegm. The symptoms of pneumonia range from mild to severe, which could be life-threatening. People from all age groups, from infants to old age, people with other health...
Nearby Providers
- Dr. Maria M Crespo MD3400 Civic Center Blvd Fl 1 Philadelphia PA 19104
- Dr. Kevin Ma M.D.3400 Civic Center Blvd Philadelphia PA 19104
- Dr. Elizabeth Malsin MD3400 Spruce St Philadelphia PA 19104
- Dr. Milton D Rossman MD3400 Spruce Street Philadelphia PA 19104
- Dr. Vivek N Ahya MD51 N 39th St Philadelphia PA 19104
- Dr. Jason Douglas Christie MD51 N 39th St Philadelphia PA 19104